Are the cardiovascular and kidney benefits of empagliflozin...

  • Main
  • 2019 / 12
  • Are the cardiovascular and kidney benefits of empagliflozin...
Diabetes, Obesity and Metabolism 2019 / 12

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?

Inzucchi, Silvio E., Fitchett, David, Jurišić‐Eržen, Dubravka, Woo, Vincent, Hantel, Stefan, Janista, Christina, Kaspers, Stefan, George, Jyothis T., Zinman, Bernard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13938
Date:
December, 2019
File:
PDF, 1.70 MB
2019
Conversion to is in progress
Conversion to is failed